NIH Researchers Identify Potential New Antiviral Drug for COVID-19: Compound Targets Essential Viral Enzyme and Prevents Replication in Cells
The experimental drug TEMPOL may be a promising oral antiviral treatment for COVID-19, suggests a study of cell cultures by…